跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈

Elsevier
通过我们出版

简介

Li Tang

Li Tang

École Polytechnique Fédérale de Lausanne (EPFL)

Li Tang is an Associate Professor of Bioengineering at EPFL, Switzerland, where he also serves as Vice Dean for Innovation. He earned his B.S. in Chemistry from Peking University (2007) and his Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign (2012), followed by a CRI Irvington Postdoctoral Fellowship at MIT. His research in immunoengineering has been recognized with many awards including ERC Consolidator (2025) and Starting Grant (2018), Leenaards Prize (2025), Friedrich Miescher Award (2025), Clarivate Highly Cited Researcher Award (2025), and Lem Prize (2025), and was named to MIT “35 Innovators Under 35” (2020, China).

Chuanbin Mao is a Global STEM Professor at the Chinese University of Hong Kong. He is an elected fellow of esteemed professional societies, including American Association for the Advancement of Science (AAAS), American Academy of Microbiology (AAM), American Chemical Society (ACS), American Institute for Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Hong Kong Institution of Engineers (HKIE), International Academy of Medical and Biological Engineering (IAMBE), Royal Society of Chemistry (RSC), and ACS Division of Polymeric Materials Science and Engineering (PMSE). He has won multiple awards such as US National Science Foundation CAREER Award. He has authored over 300 publications in top-tier journals such as Chemical Reviews, Science, Nature Materials, Nature Nanotechnology, and Nature Biomedical Engineering. His current research focuses on genetic engineering of phages to develop new strategies for disease diagnosis and treatment.